O	0	5	Human	Human	JJ	B-NP
O	6	21	cytomegalovirus	cytomegalovirus	NN	I-NP
O	22	30	elevates	elevate	VBZ	B-VP
O	31	37	levels	level	NNS	B-NP
O	38	40	of	of	IN	B-PP
O	41	44	the	the	DT	B-NP
B-Cell	45	53	cellular	cellular	JJ	I-NP
O	54	61	protein	protein	NN	I-NP
O	62	65	p53	p53	NN	I-NP
O	66	68	in	in	IN	B-PP
O	69	77	infected	infected	JJ	B-NP
B-Cell	78	89	fibroblasts	fibroblast	NNS	I-NP
O	89	90	.	.	.	O

O	92	97	Human	Human	JJ	B-NP
O	98	113	cytomegalovirus	cytomegalovirus	NN	I-NP
O	114	115	(	(	(	O
O	115	119	HCMV	HCMV	NN	B-NP
O	119	120	)	)	)	O
O	120	121	,	,	,	O
O	122	126	like	like	IN	B-PP
O	127	132	other	other	JJ	B-NP
O	133	136	DNA	DNA	NN	I-NP
B-Cancer	137	142	tumor	tumor	NN	I-NP
O	143	150	viruses	virus	NNS	I-NP
O	150	151	,	,	,	O
O	152	159	induces	induce	VBZ	B-VP
O	160	173	morphological	morphological	JJ	B-NP
O	174	188	transformation	transformation	NN	I-NP
O	189	191	of	of	IN	B-PP
B-Cell	192	197	cells	cell	NNS	B-NP
O	198	200	in	in	FW	B-ADVP
O	201	206	vitro	vitro	FW	I-ADVP
O	207	210	and	and	CC	O
O	211	221	stimulates	stimulate	VBZ	B-VP
O	222	226	host	host	NN	B-NP
B-Cell	227	231	cell	cell	NN	I-NP
O	232	246	macromolecular	macromolecular	JJ	I-NP
O	247	256	synthesis	synthesis	NN	I-NP
O	257	259	in	in	IN	B-PP
O	260	268	infected	infected	JJ	B-NP
B-Cell	269	274	cells	cell	NNS	I-NP
O	274	275	.	.	.	O

O	276	281	Since	Since	IN	B-SBAR
O	282	287	other	other	JJ	B-NP
O	288	291	DNA	DNA	NN	I-NP
B-Cancer	292	297	tumor	tumor	NN	I-NP
O	298	305	viruses	virus	NNS	I-NP
O	305	306	,	,	,	O
O	307	311	such	such	JJ	B-PP
O	312	314	as	as	IN	I-PP
O	315	321	simian	simian	JJ	B-NP
O	322	327	virus	virus	NN	I-NP
O	328	330	40	40	CD	I-NP
O	331	334	and	and	CC	I-NP
O	335	345	adenovirus	adenovirus	NN	I-NP
O	345	346	,	,	,	O
O	347	351	have	have	VBP	B-VP
O	352	362	previously	previously	RB	I-VP
O	363	367	been	be	VBN	I-VP
O	368	373	shown	show	VBN	I-VP
O	374	376	to	to	TO	I-VP
O	377	385	interact	interact	VB	I-VP
O	386	390	with	with	IN	B-PP
B-Cell	391	399	cellular	cellular	JJ	B-NP
O	400	407	protein	protein	NN	I-NP
O	408	411	p53	p53	NN	I-NP
O	411	412	,	,	,	O
O	413	415	we	we	PRP	B-NP
O	416	428	investigated	investigate	VBD	B-VP
O	429	436	whether	whether	IN	B-SBAR
O	437	446	infection	infection	NN	B-NP
O	447	449	of	of	IN	B-PP
B-Cell	450	455	cells	cell	NNS	B-NP
O	456	458	by	by	IN	B-PP
O	459	463	HCMV	HCMV	NN	B-NP
O	464	469	would	would	MD	B-VP
O	470	478	modulate	modulate	VB	I-VP
B-Cell	479	487	cellular	cellular	JJ	B-NP
O	488	491	p53	p53	NN	I-NP
O	492	498	levels	level	NNS	I-NP
O	498	499	.	.	.	O

O	500	503	Our	Our	PRP$	B-NP
O	504	511	results	result	NNS	I-NP
O	512	520	indicate	indicate	VBP	B-VP
O	521	525	that	that	IN	B-SBAR
O	526	530	HCMV	HCMV	NN	B-NP
O	531	539	elevates	elevate	VBZ	B-VP
B-Cell	540	548	cellular	cellular	JJ	B-NP
O	549	552	p53	p53	NN	I-NP
O	553	559	levels	level	NNS	I-NP
O	560	562	on	on	IN	B-PP
O	563	566	the	the	DT	B-NP
O	567	572	order	order	NN	I-NP
O	573	575	of	of	IN	B-PP
O	576	578	10	10	CD	B-NP
O	578	579	-	-	HYPH	B-ADJP
O	580	582	to	to	TO	B-PP
O	583	585	20	20	CD	B-NP
O	585	586	-	-	HYPH	O
O	586	590	fold	fold	RB	B-ADVP
O	591	593	in	in	IN	B-PP
O	594	602	infected	infected	JJ	B-NP
B-Cell	603	614	fibroblasts	fibroblast	NNS	I-NP
O	614	615	.	.	.	O

O	616	619	The	The	DT	B-NP
O	620	629	induction	induction	NN	I-NP
O	630	632	of	of	IN	B-PP
O	633	641	elevated	elevated	JJ	B-NP
O	642	645	p53	p53	NN	I-NP
O	646	652	levels	level	NNS	I-NP
O	653	656	was	be	VBD	B-VP
O	657	666	dependent	dependent	JJ	B-ADJP
O	667	671	upon	upon	IN	B-PP
O	672	675	the	the	DT	B-NP
O	676	684	presence	presence	NN	I-NP
O	685	687	of	of	IN	B-PP
O	688	694	active	active	JJ	B-NP
O	695	700	virus	virus	NN	I-NP
O	701	704	and	and	CC	O
O	705	708	was	be	VBD	B-VP
O	709	718	prevented	prevent	VBN	I-VP
O	719	721	by	by	IN	B-PP
O	722	734	neutralizing	neutralize	VBG	B-VP
O	735	743	antibody	antibody	NN	B-NP
O	743	744	.	.	.	O

O	745	748	The	The	DT	B-NP
O	749	758	induction	induction	NN	I-NP
O	759	761	of	of	IN	B-PP
O	762	770	elevated	elevated	JJ	B-NP
O	771	774	p53	p53	NN	I-NP
O	775	781	levels	level	NNS	I-NP
O	782	785	was	be	VBD	B-VP
O	786	796	determined	determine	VBN	I-VP
O	797	800	not	not	RB	O
O	801	803	to	to	TO	B-VP
O	804	806	be	be	VB	I-VP
O	807	810	due	due	IN	B-PP
O	811	813	to	to	TO	B-PP
O	814	819	virus	virus	NN	B-NP
O	819	820	-	-	HYPH	I-NP
O	820	828	receptor	receptor	NN	I-NP
O	829	841	interactions	interaction	NNS	I-NP
O	842	844	or	or	CC	O
O	845	849	HCMV	HCMV	NN	B-VP
O	850	854	late	late	JJ	B-NP
O	855	861	events	event	NNS	I-NP
O	861	862	.	.	.	O

O	863	866	The	The	DT	B-NP
O	867	876	induction	induction	NN	I-NP
O	877	879	of	of	IN	B-PP
O	880	888	elevated	elevated	JJ	B-NP
O	889	892	p53	p53	NN	I-NP
O	893	899	levels	level	NNS	I-NP
O	900	909	commenced	commence	VBN	B-VP
O	910	912	at	at	IN	B-PP
O	913	922	immediate	immediate	JJ	B-NP
O	922	923	-	-	HYPH	I-NP
O	923	928	early	early	JJ	B-NP
O	929	934	times	time	NNS	I-NP
O	935	937	of	of	IN	B-PP
O	938	941	the	the	DT	B-NP
O	942	946	HCMV	HCMV	NN	I-NP
O	947	961	multiplication	multiplication	NN	I-NP
O	962	967	cycle	cycle	NN	I-NP
O	968	969	(	(	(	O
O	969	970	6	6	CD	B-NP
O	971	972	h	h	NN	I-NP
O	973	986	postinfection	postinfection	NN	I-NP
O	986	987	)	)	)	O
O	988	991	and	and	CC	O
O	992	999	reached	reach	VBD	B-VP
O	1000	1007	maximal	maximal	JJ	B-NP
O	1008	1014	levels	level	NNS	I-NP
O	1015	1017	by	by	IN	B-PP
O	1018	1020	24	24	CD	B-NP
O	1021	1022	h	h	NN	I-NP
O	1023	1036	postinfection	postinfection	NN	I-NP
O	1036	1037	,	,	,	O
O	1038	1044	before	before	IN	B-PP
O	1045	1049	most	most	JJS	B-NP
O	1050	1052	of	of	IN	B-PP
O	1053	1056	the	the	DT	B-NP
O	1057	1061	HCMV	HCMV	NN	I-NP
O	1062	1065	DNA	DNA	NN	I-NP
O	1066	1075	synthesis	synthesis	NN	I-NP
O	1076	1079	was	be	VBD	B-VP
O	1080	1089	initiated	initiate	VBN	I-VP
O	1089	1090	.	.	.	O

O	1091	1095	HCMV	HCMV	NN	B-NP
O	1096	1105	immediate	immediate	JJ	I-NP
O	1105	1106	-	-	HYPH	I-NP
O	1106	1111	early	early	JJ	I-NP
O	1112	1120	proteins	protein	NNS	I-NP
O	1121	1125	were	be	VBD	B-VP
O	1126	1133	clearly	clearly	RB	I-VP
O	1134	1139	shown	show	VBN	I-VP
O	1140	1142	to	to	TO	I-VP
O	1143	1145	be	be	VB	I-VP
O	1146	1157	responsible	responsible	JJ	B-ADJP
O	1158	1161	for	for	IN	B-PP
O	1162	1171	elevating	elevate	VBG	B-VP
O	1172	1175	p53	p53	NN	B-NP
O	1176	1182	levels	level	NNS	I-NP
O	1183	1185	in	in	IN	B-PP
O	1186	1194	infected	infected	JJ	B-NP
B-Cell	1195	1206	fibroblasts	fibroblast	NNS	I-NP
O	1206	1207	;	;	:	O
O	1208	1218	expression	expression	NN	B-NP
O	1219	1221	of	of	IN	B-PP
O	1222	1226	HCMV	HCMV	NN	B-NP
O	1227	1236	immediate	immediate	JJ	B-ADJP
O	1236	1237	-	-	HYPH	O
O	1237	1242	early	early	JJ	B-NP
O	1243	1249	region	region	NN	I-NP
O	1250	1251	1	1	CD	B-NP
O	1252	1255	and	and	CC	I-NP
O	1256	1257	2	2	CD	I-NP
O	1258	1266	proteins	protein	NNS	I-NP
O	1267	1275	resulted	result	VBD	B-VP
O	1276	1278	in	in	IN	B-PP
O	1279	1288	elevation	elevation	NN	B-NP
O	1289	1291	of	of	IN	B-PP
O	1292	1295	p53	p53	NN	B-NP
O	1296	1302	levels	level	NNS	I-NP
O	1303	1305	in	in	IN	B-PP
O	1306	1317	transfected	transfecte	VBN	B-NP
O	1318	1323	human	human	JJ	I-NP
B-Cell	1324	1335	fibroblasts	fibroblast	NNS	I-NP
O	1335	1336	.	.	.	O

O	1337	1341	This	This	DT	B-NP
O	1342	1344	is	be	VBZ	B-VP
O	1345	1348	the	the	DT	B-NP
O	1349	1354	first	first	JJ	I-NP
O	1355	1361	report	report	NN	I-NP
O	1362	1364	of	of	IN	B-PP
O	1365	1374	increased	increase	VBN	B-NP
O	1375	1378	p53	p53	NN	I-NP
O	1379	1385	levels	level	NNS	I-NP
O	1386	1392	caused	cause	VBN	B-VP
O	1393	1395	by	by	IN	B-PP
O	1396	1400	HCMV	HCMV	NN	B-NP
O	1401	1403	in	in	IN	B-PP
O	1404	1412	infected	infected	JJ	B-NP
B-Cell	1413	1424	fibroblasts	fibroblast	NNS	I-NP
O	1424	1425	.	.	.	O

